drugset / Trial / NCT06517004
An Open-label, Single-arm Study of JWCAR201 in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label, single-arm study to investigate the efficacy and safety signals of JWCAR201 amongst subjects with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
Timeline
- Start
- 2024-07-18
- Primary completion
- 2025-12
- Completion
- 2027-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JWCAR201 | Cell therapy | 2.5e+07 cells | Intravenous |
| Subject | JWCAR201 | Cell therapy | 5e+07 cells | Intravenous |
| Subject | JWCAR201 | Cell therapy | 7.5e+07 cells | Intravenous |